These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 33210471)

  • 1. Serum pentraxin 3 as a biomarker for prognosis of acute minor stroke due to large artery atherosclerosis.
    Zhang Y; Hu H; Liu C; Wu J; Zhou S; Zhao T
    Brain Behav; 2021 Jan; 11(1):e01956. PubMed ID: 33210471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated serum pentraxin 3 levels might predict the diagnosis of branch atheromatous disease at a very early stage.
    Ninomiya I; Kanazawa M; Uemura M; Onodera O
    Eur J Neurol; 2020 Jul; 27(7):1279-1284. PubMed ID: 32250504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of high-sensitivity C-reactive protein levels in functional outcomes in patients with large-artery atherosclerosis and small-artery occlusion.
    Hou D; Liu J; Feng R; Gao Y; Wang Y; Wu J
    Neurol Res; 2017 Nov; 39(11):981-987. PubMed ID: 28749740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pentraxin 3, long expression in mononuclear cells of patients with acute coronary syndrome: Correlation with C-reactive protein and matrix metalloproteinase-9 levels.
    Ma R; Zhang W; Wang T; He X; Huang Z; Zhu J; Yao Z
    J Int Med Res; 2014 Jun; 42(3):677-83. PubMed ID: 24709882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and prognostic implications of circulating pentraxin 3 levels in non ST-elevation acute coronary syndrome.
    Eggers KM; Armstrong PW; Califf RM; Johnston N; Simoons ML; Venge P; James SK
    Clin Biochem; 2013 Nov; 46(16-17):1655-9. PubMed ID: 24012697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma pentraxin 3 levels do not predict coronary events but reflect metabolic disorders in patients with coronary artery disease in the CARE trial.
    Miyazaki T; Chiuve S; Sacks FM; Ridker PM; Libby P; Aikawa M
    PLoS One; 2014; 9(4):e94073. PubMed ID: 24705587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations of pentraxin 3 with cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis.
    Jenny NS; Blumenthal RS; Kronmal RA; Rotter JI; Siscovick DS; Psaty BM
    J Thromb Haemost; 2014 Jun; 12(6):999-1005. PubMed ID: 24628740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pentraxin 3 is a local inflammatory marker in atrial fibrillation.
    Soeki T; Bando S; Uematsu E; Matsuura T; Niki T; Ise T; Kusunose K; Hotchi J; Ueda Y; Tomita N; Yamaguchi K; Yagi S; Fukuda D; Taketani Y; Iwase T; Yamada H; Wakatsuki T; Shimabukuro M; Sata M
    Heart Vessels; 2014 Sep; 29(5):653-8. PubMed ID: 23979265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incremental prognostic significance of the elevated levels of pentraxin 3 in patients with heart failure with normal left ventricular ejection fraction.
    Matsubara J; Sugiyama S; Nozaki T; Akiyama E; Matsuzawa Y; Kurokawa H; Maeda H; Fujisue K; Sugamura K; Yamamoto E; Matsui K; Jinnouchi H; Ogawa H
    J Am Heart Assoc; 2014 Jul; 3(4):. PubMed ID: 25012287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma pentraxin 3 is associated with progression of radiographic joint damage, but not carotid atherosclerosis, in female rheumatoid arthritis patients: 3-year prospective study.
    Asanuma YF; Aizaki Y; Noma H; Yokota K; Matsuda M; Kozu N; Takebayashi Y; Nakatani H; Hasunuma T; Kawai S; Mimura T
    Mod Rheumatol; 2020 Nov; 30(6):959-966. PubMed ID: 31615315
    [No Abstract]   [Full Text] [Related]  

  • 11. Pentraxin-3 concentrations in stable coronary artery disease depend on the clinical presentation.
    Hudzik B; Danikiewicz A; Szkodzinski J; Polonski L; Zubelewicz-Szkodzinska B
    Eur Cytokine Netw; 2014; 25(3):41-5. PubMed ID: 25373851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction.
    Latini R; Maggioni AP; Peri G; Gonzini L; Lucci D; Mocarelli P; Vago L; Pasqualini F; Signorini S; Soldateschi D; Tarli L; Schweiger C; Fresco C; Cecere R; Tognoni G; Mantovani A;
    Circulation; 2004 Oct; 110(16):2349-54. PubMed ID: 15477419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of pentraxin 3 in patients with chronic heart failure.
    Kotooka N; Inoue T; Aoki S; Anan M; Komoda H; Node K
    Int J Cardiol; 2008 Oct; 130(1):19-22. PubMed ID: 18045709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated levels of systemic pentraxin 3 are associated with thin-cap fibroatheroma in coronary culprit lesions: assessment by optical coherence tomography and intravascular ultrasound.
    Koga S; Ikeda S; Yoshida T; Nakata T; Takeno M; Masuda N; Koide Y; Kawano H; Maemura K
    JACC Cardiovasc Interv; 2013 Sep; 6(9):945-54. PubMed ID: 23954061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum vascular endothelial growth factor as a biomarker for prognosis of minor ischemic stroke.
    Zhang Y; Ma T; Hu H; Wang J; Zhou S
    Clin Neurol Neurosurg; 2020 Sep; 196():106060. PubMed ID: 32645625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pentraxin-3 in Thrombolytic Therapy for Acute Ischemic Stroke: No Relation with Curative Effect and Prognosis.
    Zhang CY; Han HD; Wang SY; Huang SR; Deng BQ
    Med Sci Monit; 2018 Jun; 24():4427-4432. PubMed ID: 29949524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic and diagnostic potential of local and circulating levels of pentraxin 3 in lung cancer patients.
    Infante M; Allavena P; Garlanda C; Nebuloni M; Morenghi E; Rahal D; Roncalli M; Cavuto S; Pesce S; Monari M; Valaperta S; Montanelli A; Solomon D; Bottoni E; Errico V; Voulaz E; Bossi M; Chiesa G; Passera E; Mantovani A; Alloisio M
    Int J Cancer; 2016 Feb; 138(4):983-91. PubMed ID: 26348770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pentraxin-3 as a local inflammatory marker in chronic spontaneous urticaria.
    Kasperska-Zajac A; Grzanka A; Misiolek M; Mazur B; Machura E
    Cytokine; 2015 Dec; 76(2):566-568. PubMed ID: 25982553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pentraxin 3 is associated with disease activity but not atherosclerosis in patients with systemic lupus erythematosus.
    Shimada Y; Asanuma YF; Yokota K; Yoshida Y; Kajiyama H; Sato K; Akiyama Y; Mimura T
    Mod Rheumatol; 2014 Jan; 24(1):78-85. PubMed ID: 24261762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating pentraxin 3 levels are higher in metabolic syndrome with subclinical atherosclerosis: evidence for association with atherogenic lipid profile.
    Zanetti M; Bosutti A; Ferreira C; Vinci P; Biolo G; Fonda M; Valente M; Cattin L; Guarnieri G; Barazzoni R
    Clin Exp Med; 2009 Sep; 9(3):243-8. PubMed ID: 19238513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.